Sangamo (SGMO) shares are up 33c, or 53%, to 95c in after-hours trading after the company announced the deal with Eli Lilly (LLY).
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGMO:
- Sangamo announces capsid license agreement with Eli Lilly
- 3 Best Stocks to Buy Now, 3/19/2025, According to Top Analysts
- Sangamo Biosciences: Navigating Competitive Pressures and Strategic Risks in Genomic Medicine
- Sangamo Biosciences’ Earnings Call Highlights Progress and Challenges
- 3 Best Stocks to Buy Now, 3/18/2025, According to Top Analysts
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue